GenesisCare backs innovation in cancer pharmaceutical market with $5M investment in Clarity Pharmaceuticals
Sydney, Australia 13 September 2018 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of cancer, cardiovascular disease and fibrosis, has received a strategic investment of $5 million from GenesisCare, the largest private provider of cancer treatment in Australia and Europe. The funds will go towards the development of Clarity’s clinical pipeline, aligning with…